Companies
GSK
STOXX 600Health Care· United Kingdom

GSK

Status-Quo-Player

GSK

$2,131.00

-2.69%

Open $2,198.00·Prev $2,190.00

Delayed

STATUS-QUO-PLAYER

Power Core

GSK's moat is the integration of global vaccine manufacturing scale with durable HIV franchise dominance that creates compounding regulatory and distribution barriers.

Published15 Apr 2026
UniverseSTOXX 600
SectorHealth Care

Direction of Movement

upward

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
GSK:XLON — GSK — Power Mapping Analysis — L17X — L17X